Início
Reels
Grupos
Páginas
Ver Mais
Grupos Páginas Eventos Blogs Funding
Entrar Registrar
Night Mode
Autologous vs. Allogeneic: The CAR T Manufacturing Race
The promise of CAR T therapy is constrained by a manufacturing challenge: creating personalized treatments at scale is complex, time-consuming, and expensive. Autologous therapy—using the patient's own cells—requires a bespoke manufacturing process for each patient, with vein-to-vein times that can delay treatment. Allogeneic therapy—using donor cells—offers the...
0 Comentários ·0 Compartilhamentos ·21 Visualizações ·0 Anterior
Faça Login para curtir, compartilhar e comentar!